全文获取类型
收费全文 | 157578篇 |
免费 | 15927篇 |
国内免费 | 9252篇 |
专业分类
耳鼻咽喉 | 1262篇 |
儿科学 | 2076篇 |
妇产科学 | 1809篇 |
基础医学 | 23274篇 |
口腔科学 | 2865篇 |
临床医学 | 18844篇 |
内科学 | 21376篇 |
皮肤病学 | 1777篇 |
神经病学 | 7729篇 |
特种医学 | 5509篇 |
外国民族医学 | 68篇 |
外科学 | 15343篇 |
综合类 | 26460篇 |
现状与发展 | 33篇 |
一般理论 | 18篇 |
预防医学 | 10965篇 |
眼科学 | 3894篇 |
药学 | 18018篇 |
141篇 | |
中国医学 | 8927篇 |
肿瘤学 | 12369篇 |
出版年
2024年 | 213篇 |
2023年 | 2228篇 |
2022年 | 3996篇 |
2021年 | 7226篇 |
2020年 | 5909篇 |
2019年 | 5236篇 |
2018年 | 5541篇 |
2017年 | 5044篇 |
2016年 | 4803篇 |
2015年 | 7016篇 |
2014年 | 8614篇 |
2013年 | 8494篇 |
2012年 | 11950篇 |
2011年 | 12685篇 |
2010年 | 8907篇 |
2009年 | 7258篇 |
2008年 | 8815篇 |
2007年 | 8815篇 |
2006年 | 8094篇 |
2005年 | 7263篇 |
2004年 | 5687篇 |
2003年 | 5537篇 |
2002年 | 4727篇 |
2001年 | 3890篇 |
2000年 | 3422篇 |
1999年 | 2990篇 |
1998年 | 1852篇 |
1997年 | 1930篇 |
1996年 | 1362篇 |
1995年 | 1369篇 |
1994年 | 1214篇 |
1993年 | 834篇 |
1992年 | 1092篇 |
1991年 | 990篇 |
1990年 | 870篇 |
1989年 | 795篇 |
1988年 | 724篇 |
1987年 | 616篇 |
1986年 | 574篇 |
1985年 | 466篇 |
1984年 | 404篇 |
1983年 | 325篇 |
1982年 | 286篇 |
1981年 | 242篇 |
1980年 | 213篇 |
1979年 | 229篇 |
1978年 | 201篇 |
1977年 | 226篇 |
1976年 | 200篇 |
1974年 | 159篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
目的:探讨细胞骨架调节剂(lncRNA cytoskeleton regulator,CYTOR)是否通过靶向调控miR-503来促进细胞周期蛋白E1(cyclin E1,CCNE1)影响上皮性卵巢癌增殖。方法:实时定量聚合酶链反应(RT-qPCR)检测CYTOR在不同临床分期、病理分级和有无淋巴结转移患者人上皮性卵巢癌组织、癌旁组织和正常组织以及不同卵巢癌细胞中的表达;starBase数据库(网址:http://starbase.sysu.edu.cn/)预测分析CYTOR和miR-503以及miR-503与CCNE1之间的关系,同时荧光素酶实验进行验证;RT-qPCR和免疫荧光分别检测miR-503与CCNE1在人上皮性卵巢癌组织、癌旁组织和正常组织以及不同卵巢癌细胞中的表达;RNA转染技术在A2780中细胞分别沉默CYTOR、过表达miR-503和沉默CCNE1表达,CCK-8检测各组细胞增殖能力变化;RT-qPCR和免疫荧光检测沉默CYTOR后miR-503和CCNE1的表达以及过表达miR-503后CCNE1的表达。结果:CYTOR和CCNE1在上皮性卵巢癌组织中表达增加,同时在临床分期III-IV期、病理分级G_(3)级、淋巴结转移阳性患者肿瘤组织中表达同样显著增加且导致卵巢癌患者术后预后较差;通过数据库分析CYTOR可直接靶向抑制miR-503,而miR-503可直接靶向抑制CCNE1表达,双荧光素酶实验结果与之相同;CYTOR和CCNE1促进上皮性卵巢癌增殖,而miR-503抑制上皮性卵巢癌增殖作用。结论:lncRNA CYTOR通过调控miR-503/CCNE1轴促进上皮性卵巢癌的增殖。 相似文献
22.
Tsibin A. Yu. Berkovich A. E. Bursian A. A. Ulimbasheva Z. M. Vakhitov M. Sh. 《Biomedical engineering》2022,56(2):124-127
Biomedical Engineering - We present here an experimental study demonstrating the action of noninvasive high-intensity focused ultrasound (HIFU) on vein walls in the treatment of varicose disease.... 相似文献
23.
Post-induction hypotension is common and associated with postoperative complications. We hypothesised that pneumatic leg compression reduces post-induction hypotension in elderly patients undergoing robot-assisted laparoscopic prostatectomy. In this double-blind randomised study, patients were allocated randomly to the pneumatic leg compression group (n = 50) or control (n = 50). In the intervention group, pneumatic leg compression was initiated before induction of anaesthesia. In the control group, pneumatic leg compression was initiated 20 min after anaesthesia induction. The primary outcome was the incidence of post-induction hypotension in these groups. Post-induction hypotension was defined as systolic blood pressure < 90 mmHg during the first 20 min after induction. Haemodynamic variables and area under the curve of post-induction systolic blood pressure over time were assessed. Complications associated with pneumatic leg compression were recorded, including: peripheral neuropathy; compartment syndrome; extensive bullae beneath the leg sleeves; and pulmonary thromboembolism. The incidence of post-induction hypotension decreased in the pneumatic leg compression group compared with that in the control group; 5 (10%) vs. 29 (58%), respectively, p < 0.001. In the pneumatic leg compression group, the lowest systolic, diastolic and mean blood pressures 20 min after induction of anaesthesia were significantly greater than the control group. Pneumatic leg compression resulted in an increased area under the curve of systolic blood pressure in the first 20 min after induction, p = 0.001. There were no pneumatic leg compression-related complications. Pneumatic leg compression reduced post-induction hypotension in elderly patients undergoing robot-assisted laparoscopic prostatectomy, suggesting that it is an effective and safe intervention to prevent post-induction hypotension among elderly patients undergoing general anaesthesia. 相似文献
24.
Weina Cheng Yazhi Wang Jingxian Liu Xiaofei Li Ming Yu Cancan Duan Liu Liu Jianyong Zhang 《Journal of applied toxicology : JAT》2022,42(6):970-980
Cantharidin (CTD) is an effective antitumor agent. However, it exhibits significant hepatotoxicity, the mechanism of which remains unclear. In this study, biochemical and histopathological analyses complemented with ultra-high-performance liquid chromatography–tandem mass spectrometry (UHPLC-MS/MS)-based targeted metabolomic analysis of bile acids (BAs) were employed to investigate CTD-induced hepatotoxicity in rats. Sixteen male and female Sprague–Dawley rats were randomly divided into two groups: control and CTD (1.0 mg/kg) groups. Serum and liver samples were collected after 28 days of intervention. Biochemical, histopathological, and BA metabolomic analyses were performed for all samples. Further, the key biomarkers of CTD-induced hepatotoxicity were identified via multivariate and metabolic pathway analyses. In addition, metabolite–gene–enzyme network and Kyoto Encyclopedia of Genes and Genomes pathway analyses were used to identify the signaling pathways related to CTD-induced hepatotoxicity. The results revealed significantly increased levels of biochemical indices (alanine aminotransferase, aspartate aminotransferase, and total bile acid). Histopathological analysis revealed that the hepatocytes were damaged. Further, 20 endogenous BAs were quantitated via UHPLC-MS/MS, and multivariate and metabolic pathway analyses of BAs revealed that hyocholic acid, cholic acid, and chenodeoxycholic acid were the key biomarkers of CTD-induced hepatotoxicity. Meanwhile, primary and secondary BA biosynthesis and taurine and hypotaurine metabolism were found to be associated with the mechanism by which CTD induced hepatotoxicity in rats. This study provides useful insights for research on the mechanism of CTD-induced hepatotoxicity. 相似文献
25.
27.
目的 探讨糖尿病前期的中医证型及证素分布特点。方法 检索中国知网、万方及维普三大数据库中收录的自建库以来有关糖尿病前期证型的临床研究文献,对中医证型进行规范整理,建立数据库,提取证素,运用数据挖掘技术中的关联分析、聚类分析探究证素分布规律。结果 共纳入10篇文献,总有效病例1620例,证型经规范处理后整理为18个,主要证型为脾虚痰湿证。共提取证素13个,主要病位证素为脾,主要病性证素为气虚、湿和痰,关联分析显示脾—湿支持度和置信度最高,聚类分析结果可得到3个聚类组。结论 糖尿病前期病位在脾,气虚、脾、痰、湿是常见证素,临床诊治糖尿病前期应注重从脾论治,需辨证施治。 相似文献
28.
29.
30.
目的 探讨长链非编码RNA PITPNA-AS1在卵巢癌中的作用及其可能的分子机制。方法 采用荧光实时定量聚合酶链式反应(qPCR)技术检测卵巢癌组织和对应的癌旁组织、卵巢癌细胞系和正常卵巢上皮细胞系中PITPNA-AS1的表达水平。将PITPNA-AS1表达最少的细胞系分为对照组和实验组,分别转染阴性对照质粒或PITPNA-AS1质粒。细胞计数实验(CCK-8)法和Transwell法检测细胞的增殖活性和侵袭能力。生物信息学方法预测和双荧光素酶活性报告基因实验验证PITPNA-AS1作用的分子机制。qPCR和Western blot检测PITPNA-AS1相互作用的基因表达。结果 PITPNA-AS1在卵巢癌组织中表达低于癌旁组织(P<0.01)。PITPNA-AS1在卵巢癌细胞系中的表达水平均低于正常卵巢上皮细胞(P<0.05),OVCAR-3细胞表达最少(P<0.01)。与对照组比较,过表达PITPNA-AS1能抑制OVCAR-3细胞的增殖活力(P<0.05)和侵袭能力(P<0.01)。PITPNA-AS1与miR-92a-3p存在靶向关系(P<... 相似文献